Lifespan partnership receives $2.7M grant for early-detection technology

LIFESPAN CORP. and California-based digital health company Eko have teamed up to develop a low-cost tool to diagnose pulmonary hypertension, with support from a $2.7 million Small Business Innovation Research grant. / COURTESY EKO
PROVIDENCE – Pulmonary hypertension, a type of high blood pressure, can have debilitating and deadly outcomes. But the “gold standard” for early detection is expensive and invasive, often leading to more than two-year delays in diagnosis and poorer outcomes. In an effort to make early detection more accessible, Lifespan Corp. and California-based digital health company Eko have teamed up to…

This week only register to receive unlimited access to all content. Ends October 8th.

Register Now

Already a Subscriber?

Login now

- Advertisement -

If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display